Randomized, Double-Blind Clinical Evaluation of the Efficacy and Safety of Topical Eflornithine HCl 13.9% Cream in the Treatment of Women with Facial Hair

    John E. Wolf, Douglas Shander, Ferdinand Huber, Joseph Jackson, Chensheng Lin, Barbara Mathes, Kathy Schrode
    TLDR The cream effectively and safely reduces facial hair in women.
    The study conducted a randomized, double-blind clinical trial to evaluate the efficacy and safety of topical eflornithine HCl 13.9% cream for treating facial hair in women. The research involved a collaboration between Baylor College of Medicine, Gillette Advanced Technology Center, and Bristol-Myers Squibb. The results demonstrated that eflornithine HCl 13.9% cream was effective in reducing facial hair growth in women, providing a viable treatment option for this condition. The study also confirmed the safety of the cream, making it a promising solution for women seeking to manage unwanted facial hair.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    2 / 2 results

    Similar Research

    6 / 193 results